BENITEC BIOPHARMA INC (BNTC) Stock Income Statement
NASDAQ:BNTC - Nasdaq - US08205P2092 - Common Stock - Currency: USD
| TTM (2024-12-31) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 80.00K | 70.00K | 60.00K | |||
| Cost Of Goods | -3.00K | -108.00K | 0.00 | 10.00K | 120.00K | |||
| Gross Profit | 3.00K | 108.00K | 80.00K | 60.00K | -60.00K | |||
| Operating Expenses | 24.09M | 22.60M | 19.16M | 17.92M | 13.54M | |||
| Research and Development | 14.73M | 15.61M | 12.77M | 11.27M | 7.02M | |||
| Selling, General, and Administrative Expenses | 9.36M | 6.99M | 6.38M | 6.65M | 6.51M | |||
| Operating Income | -24.09M | -22.49M | -19.08M | -17.85M | -13.60M | |||
| Interest Income/Expense | 2.09M | 943.00K | -450.00K | -280.00K | -320.00K | |||
| Other Income/Expense | -175.00K | -204.00K | -30.00K | -80.00K | 40.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -21.41M | -21.75M | -19.56M | -18.21M | -13.88M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -22.03M | -22.37M | -19.56M | -18.21M | -13.88M | |||
| EBITDA | -23.57M | -22.15M | N/A | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.04 | -5.51 | -14.07 | -37.93 | -55.52 | |||
| Non GAAP EPS | -3.77 | -8.36 | -16.94 | -1.02 | -3.21 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | 100.00% | 85.71% | -100.00% | |||
| Profit Margin | N/A | N/A | -24450.00% | -26014.29% | -23133.33% | |||
| Operating Profit Margin | N/A | N/A | -23850.00% | -25500.00% | -22666.67% | |||
All data in USD